HIGHLIGHTS
- who: Jingyun Liu et al. from the Department of Histology and Embryology, College of Basic Medical Sciences, Dalian Medical University, Dalian, China have published the Article: A Class I HDAC Inhibitor BG45 Alleviates Cognitive Impairment through the CaMKII/ITPKA/Ca2+ Signaling Pathway, in the Journal: Pharmaceuticals 2022, 1481 of 10/Dec/2021
- what: In this work the effect of the histone deacetylase (HDACI) on synapse-related proteins was investigated in primary neurons from APP/PS1 transgenic mice.
- how: The results showed that can upregulate the expression of synaptotagmin-1 (SYT-1) and neurofilament . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.